Comparison of GSK3389404 plasma PK across Asia-Pacific populations.
The GSK3389404 plasma concentration-versus-time profiles were similar across the populations from mainland China, Hong Kong, Japan, South Korea, Singapore, and the Philippines at the same dose level, following single or multiple doses (GSK3389404 dose-normalized plasma (A) C